Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$21.80
+7.98%
Mkt Cap $2.31B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (19 analysts)
$32.67
Range $24.00 – $40.00
Implied Upside
+49.9%
Consensus $32.67 vs current $21.80
NASDAQ·Healthcare·Biotechnology
$21.80
+7.98%
Mkt Cap $2.31B
Buy
8
Hold
0
Sell
0
Price Target (19 analysts)
$32.67
Range $24.00 – $40.00
+49.9%
Consensus $32.67 vs current $21.80